Loading
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$4.46
−$0.13 · -2.83%
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.
Previous close
$4.46
−$0.13 · -2.83%
After-hours
$4.44
−$0.02 · -0.45%
Oct 7, 7:59 PM ET
Regular session · ET · Market data may be delayed.
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.
Day range
Current $4.46
52-week range
Current $4.46
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
47
Fair Value
Sentiment
46
Mixed
Risk
62
High Risk
Momentum
21
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.
Day range
Current $4.46
52-week range
Current $4.46
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CAD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 320.59M CAD | 343.29M CAD | 270.28M CAD | 223.8M CAD | 221.34M CAD |
| Cost of goods sold | 183.94M CAD | 155.69M CAD | 138.82M CAD | 209.02M CAD | 200.11M CAD |
| Gross profit | 136.65M CAD | 187.61M CAD | 131.46M CAD | 14.78M CAD | 21.23M CAD |
| Research and development | 4.02M CAD | 3.68M CAD | 3.57M CAD | 5.77M CAD | 10.39M CAD |
| Selling, general, and administrative | 166.21M CAD | 166.47M CAD | 156.88M CAD | 170.48M CAD | 188.99M CAD |
| Operating expenses | 183.31M CAD | 182.66M CAD | 177.91M CAD | 221.98M CAD | 252.67M CAD |
| Interest income | 5.85M CAD | 11.51M CAD | 12.81M CAD | 19M CAD | 4.51M CAD |
| Interest expense | 1.81M CAD | 8.42M CAD | 14.19M CAD | 39.46M CAD | 71.81M CAD |
| Depreciation and amortization | 14.19M CAD | 22.55M CAD | 32.78M CAD | 42.75M CAD | 93.66M CAD |
| Operating income | −46.66M CAD | 4.95M CAD | −46.45M CAD | −207.19M CAD | −231.45M CAD |
| Net income | −121.76M CAD | 1.59M CAD | −69.33M CAD | −816.63M CAD | −1.74B CAD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$5.92
32.74% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Amplify Alternative Harvest ETFMJ5.68M5.34%107.23M USD1.12%$24.37-0.53%
AdvisorShares Pure Cannabis ETFYOLO1.96M5.96%32.94M USD0.91%$2.765-1.20%
Kraneshares Dragon Capital Vietnam Growth Index ETFKPHO423.78K3.81%11.11M USD1.02%$22.11030.00%
Morgan Stanley ETF Trust - Eaton Vance Strategic Income Opportunities ETFXAGG84.52K—1.9B USD0.50%$48.33-0.08%
Dimensional - International Core Equity 2 ETFDFIC31.78K0.00%15.2B USD0.22%$37.34-1.11%Amplify Alternative Harvest ETFMJAdvisorShares Pure Cannabis ETFYOLOKraneshares Dragon Capital Vietnam Growth Index ETFKPHOMorgan Stanley ETF Trust - Eaton Vance Strategic Income Opportunities ETFXAGGDimensional - International Core Equity 2 ETFDFICAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
